TY - JOUR
T1 - Effectiveness of computerized decision support systems linked to electronic health records
T2 - A systematic review and meta-analysis
AU - Moja, Lorenzo
AU - Kwag, Koren H.
AU - Lytras, Theodore
AU - Bertizzolo, Lorenzo
AU - Brandt, Linn
AU - Pecoraro, Valentina
AU - Rigon, Giulio
AU - Vaona, Alberto
AU - Ruggiero, Francesca
AU - Mangia, Massimo
AU - Iorio, Alfonso
AU - Kunnamo, Ilkka
AU - Bonovas, Stefanos
PY - 2014/12/1
Y1 - 2014/12/1
N2 - We systematically reviewed randomized controlled trials (RCTs) assessing the effectiveness ofcomputerized decision support systems (CDSSs) featuring rule- or algorithm-based software integrated with electronic health records (EHRs) and evidence-based knowledge. We searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and Cochrane Database of Abstracts of Reviews of Effects. Information on system design, capabilities, acquisition, implementation context, and effects on mortality, morbidity, and economic outcomes were extracted. Twenty-eight RCTs were included. CDSS use did not affect mortality (16 trials, 37395 patients; 2282 deaths; risk ratio [RR] = 0.96; 95%confidence interval [CI] = 0.85, 1.08; I2 = 41%).Astatistically significant effect was evident in the prevention ofmorbidity, any disease (9 RCTs; 13868 patients;RR = 0.82; 95% CI = 0.68, 0.99; I2 = 64%), but selectiveoutcomereporting or publication bias cannot be excluded. We observed differences for costs and health service utilization, although these were often small in magnitude. Across clinical settings, new generation CDSSs integrated with EHRs do not affect mortality and might moderately improvemorbidity outcomes.
AB - We systematically reviewed randomized controlled trials (RCTs) assessing the effectiveness ofcomputerized decision support systems (CDSSs) featuring rule- or algorithm-based software integrated with electronic health records (EHRs) and evidence-based knowledge. We searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and Cochrane Database of Abstracts of Reviews of Effects. Information on system design, capabilities, acquisition, implementation context, and effects on mortality, morbidity, and economic outcomes were extracted. Twenty-eight RCTs were included. CDSS use did not affect mortality (16 trials, 37395 patients; 2282 deaths; risk ratio [RR] = 0.96; 95%confidence interval [CI] = 0.85, 1.08; I2 = 41%).Astatistically significant effect was evident in the prevention ofmorbidity, any disease (9 RCTs; 13868 patients;RR = 0.82; 95% CI = 0.68, 0.99; I2 = 64%), but selectiveoutcomereporting or publication bias cannot be excluded. We observed differences for costs and health service utilization, although these were often small in magnitude. Across clinical settings, new generation CDSSs integrated with EHRs do not affect mortality and might moderately improvemorbidity outcomes.
UR - http://www.scopus.com/inward/record.url?scp=84911092331&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84911092331&partnerID=8YFLogxK
U2 - 10.2105/AJPH.2014.302164
DO - 10.2105/AJPH.2014.302164
M3 - Article
C2 - 25322302
AN - SCOPUS:84911092331
SN - 0090-0036
VL - 104
SP - e12-e22
JO - American Journal of Public Health
JF - American Journal of Public Health
IS - 12
ER -